Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Jul;30(1):172–173. doi: 10.1128/aac.30.1.172

Susceptibility of Eikenella corrodens to newer and older quinolones.

E J Goldstein, D M Citron, A E Vagvolgyi, M E Gombert
PMCID: PMC176458  PMID: 3530124

Abstract

The susceptibilities of 44 clinical strains and a reference strain (ATCC 23834) of Eikenella corrodens were determined by agar dilution. All isolates were very susceptible (MICs, less than 2 micrograms/ml) to amifloxacin, ciprofloxacin, difloxacin, enoxacin, norfloxacin, ofloxacin, and Win 35439.

Full text

PDF
172

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brooks G. F., O'Donoghue J. M., Rissing J. P., Soapes K., Smith J. W. Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse. Medicine (Baltimore) 1974 Sep;53(5):325–342. [PubMed] [Google Scholar]
  2. Dorff G. J., Jackson L. J., Rytel M. W. Infections with Eikenella corrodens. A newly recognized human pathogen. Ann Intern Med. 1974 Mar;80(3):305–309. doi: 10.7326/0003-4819-80-3-305. [DOI] [PubMed] [Google Scholar]
  3. Geraci J. E., Hermans P. E., Washington J. A., 2nd Eikenella corrodens endocarditis: report of cure in two cases. Mayo Clin Proc. 1974 Dec;49(12):950–953. [PubMed] [Google Scholar]
  4. Goldstein E. J., Barones M. F., Miller T. A. Eikenella corrodens in hand infections. J Hand Surg Am. 1983 Sep;8(5 Pt 1):563–567. doi: 10.1016/s0363-5023(83)80126-9. [DOI] [PubMed] [Google Scholar]
  5. Goldstein E. J., Sutter V. L., Finegold S. M. Susceptibility of Eikenella corrodens to ten cephalosporins. Antimicrob Agents Chemother. 1978 Oct;14(4):639–641. doi: 10.1128/aac.14.4.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goodman A. D. Eikenella corrodens isolated in oral infections of dental origin. Oral Surg Oral Med Oral Pathol. 1977 Jul;44(1):128–134. doi: 10.1016/0030-4220(77)90254-7. [DOI] [PubMed] [Google Scholar]
  7. Hooper D. C., Wolfson J. S. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother. 1985 Nov;28(5):716–721. doi: 10.1128/aac.28.5.716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kaplan J. M., McCracken G. H., Jr, Nelson J. D. Infections in children caused by the HB group of bacteria. J Pediatr. 1973 Mar;82(3):398–403. doi: 10.1016/s0022-3476(73)80112-x. [DOI] [PubMed] [Google Scholar]
  9. Perez Trallero E., Garcia Arenzana J. M., Cilla Eguiluz G., Tovar Larrucea J. Beta-lactamase-producing Eikenella corrodens in an intraabdominal abscess. J Infect Dis. 1986 Feb;153(2):379–380. doi: 10.1093/infdis/153.2.379. [DOI] [PubMed] [Google Scholar]
  10. Robinson J. V., James A. L. In vitro susceptibility of Bacteroides corrodens and Eikenella corrodens to ten chemotherapeutic agents. Antimicrob Agents Chemother. 1974 Nov;6(5):543–546. doi: 10.1128/aac.6.5.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sinkovics J. G., Plager C., Mills K. Eikenella corrodens as pathogen. Ann Intern Med. 1979 Jun;90(6):991–991. doi: 10.7326/0003-4819-90-6-991_1. [DOI] [PubMed] [Google Scholar]
  12. Suwanagool S., Rothkopf M. M., Smith S. M., LeBlanc D., Eng R. Pathogenicity of Eikenella corrodens in humans. Arch Intern Med. 1983 Dec;143(12):2265–2268. [PubMed] [Google Scholar]
  13. Wolfson J. S., Hooper D. C. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother. 1985 Oct;28(4):581–586. doi: 10.1128/aac.28.4.581. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES